Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Peripheral Intervention Drug-Eluting Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Intervention Drug-Eluting Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Intervention Drug-Eluting Devices Overall Market Size
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size: 2021 VS 2028
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peripheral Intervention Drug-Eluting Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Peripheral Intervention Drug-Eluting Devices Players in Global Market
3.2 Top Global Peripheral Intervention Drug-Eluting Devices Companies Ranked by Revenue
3.3 Global Peripheral Intervention Drug-Eluting Devices Revenue by Companies
3.4 Global Peripheral Intervention Drug-Eluting Devices Sales by Companies
3.5 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peripheral Intervention Drug-Eluting Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peripheral Intervention Drug-Eluting Devices Players in Global Market
3.8.1 List of Global Tier 1 Peripheral Intervention Drug-Eluting Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Peripheral Intervention Drug-Eluting Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Intervention Drug-Eluting Devices Market Size Markets, 2021 & 2028
4.1.2 Drug-Eluting Balloons
4.1.3 Drug-Eluting Stents
4.2 By Type - Global Peripheral Intervention Drug-Eluting Devices Revenue & Forecasts
4.2.1 By Type - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2022
4.2.2 By Type - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2023-2028
4.2.3 By Type - Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Peripheral Intervention Drug-Eluting Devices Sales & Forecasts
4.3.1 By Type - Global Peripheral Intervention Drug-Eluting Devices Sales, 2017-2022
4.3.2 By Type - Global Peripheral Intervention Drug-Eluting Devices Sales, 2023-2028
4.3.3 By Type - Global Peripheral Intervention Drug-Eluting Devices Sales Market Share, 2017-2028
4.4 By Type - Global Peripheral Intervention Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Peripheral Intervention Drug-Eluting Devices Market Size, 2021 & 2028
5.1.2 Plain Old Balloon Angioplasty (POBA)
5.1.3 Percutaneous Transluminal Angioplasty (PTA)
5.2 By Application - Global Peripheral Intervention Drug-Eluting Devices Revenue & Forecasts
5.2.1 By Application - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2022
5.2.2 By Application - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2023-2028
5.2.3 By Application - Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Peripheral Intervention Drug-Eluting Devices Sales & Forecasts
5.3.1 By Application - Global Peripheral Intervention Drug-Eluting Devices Sales, 2017-2022
5.3.2 By Application - Global Peripheral Intervention Drug-Eluting Devices Sales, 2023-2028
5.3.3 By Application - Global Peripheral Intervention Drug-Eluting Devices Sales Market Share, 2017-2028
5.4 By Application - Global Peripheral Intervention Drug-Eluting Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Peripheral Intervention Drug-Eluting Devices Market Size, 2021 & 2028
6.2 By Region - Global Peripheral Intervention Drug-Eluting Devices Revenue & Forecasts
6.2.1 By Region - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2022
6.2.2 By Region - Global Peripheral Intervention Drug-Eluting Devices Revenue, 2023-2028
6.2.3 By Region - Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Peripheral Intervention Drug-Eluting Devices Sales & Forecasts
6.3.1 By Region - Global Peripheral Intervention Drug-Eluting Devices Sales, 2017-2022
6.3.2 By Region - Global Peripheral Intervention Drug-Eluting Devices Sales, 2023-2028
6.3.3 By Region - Global Peripheral Intervention Drug-Eluting Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2028
6.4.2 By Country - North America Peripheral Intervention Drug-Eluting Devices Sales, 2017-2028
6.4.3 US Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.4.4 Canada Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.4.5 Mexico Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2028
6.5.2 By Country - Europe Peripheral Intervention Drug-Eluting Devices Sales, 2017-2028
6.5.3 Germany Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.4 France Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.5 U.K. Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.6 Italy Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.7 Russia Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.8 Nordic Countries Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.5.9 Benelux Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2028
6.6.2 By Region - Asia Peripheral Intervention Drug-Eluting Devices Sales, 2017-2028
6.6.3 China Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.6.4 Japan Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.6.5 South Korea Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.6.6 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.6.7 India Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2028
6.7.2 By Country - South America Peripheral Intervention Drug-Eluting Devices Sales, 2017-2028
6.7.3 Brazil Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.7.4 Argentina Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales, 2017-2028
6.8.3 Turkey Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.8.4 Israel Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
6.8.6 UAE Peripheral Intervention Drug-Eluting Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Medtronic plc
7.1.1 Medtronic plc Corporate Summary
7.1.2 Medtronic plc Business Overview
7.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.1.5 Medtronic plc Key News
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Corporate Summary
7.2.2 Boston Scientific Corporation Business Overview
7.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.2.5 Boston Scientific Corporation Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.3.5 Abbott Laboratories Key News
7.4 Cardinal Health
7.4.1 Cardinal Health Corporate Summary
7.4.2 Cardinal Health Business Overview
7.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.4.5 Cardinal Health Key News
7.5 B. Braun Melsungen AG
7.5.1 B. Braun Melsungen AG Corporate Summary
7.5.2 B. Braun Melsungen AG Business Overview
7.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.5.5 B. Braun Melsungen AG Key News
7.6 Biosensors International Group Ltd.
7.6.1 Biosensors International Group Ltd. Corporate Summary
7.6.2 Biosensors International Group Ltd. Business Overview
7.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.6.5 Biosensors International Group Ltd. Key News
7.7 C.R. Bard, Inc.
7.7.1 C.R. Bard, Inc. Corporate Summary
7.7.2 C.R. Bard, Inc. Business Overview
7.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.7.5 C.R. Bard, Inc. Key News
7.8 Abbott
7.8.1 Abbott Corporate Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.8.5 Abbott Key News
7.9 The Lubrizol Corporation
7.9.1 The Lubrizol Corporation Corporate Summary
7.9.2 The Lubrizol Corporation Business Overview
7.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.9.5 The Lubrizol Corporation Key News
7.10 Terumo Corporation
7.10.1 Terumo Corporation Corporate Summary
7.10.2 Terumo Corporation Business Overview
7.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Major Product Offerings
7.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales and Revenue in Global (2017-2022)
7.10.5 Terumo Corporation Key News
8 Global Peripheral Intervention Drug-Eluting Devices Production Capacity, Analysis
8.1 Global Peripheral Intervention Drug-Eluting Devices Production Capacity, 2017-2028
8.2 Peripheral Intervention Drug-Eluting Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Peripheral Intervention Drug-Eluting Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peripheral Intervention Drug-Eluting Devices Supply Chain Analysis
10.1 Peripheral Intervention Drug-Eluting Devices Industry Value Chain
10.2 Peripheral Intervention Drug-Eluting Devices Upstream Market
10.3 Peripheral Intervention Drug-Eluting Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peripheral Intervention Drug-Eluting Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer